Eli Lilly pausing investment in UK as report warns against ‘limited’ NHS uptake of new drugs – The Pharmaceutical Journal

  1. Eli Lilly pausing investment in UK as report warns against ‘limited’ NHS uptake of new drugs  The Pharmaceutical Journal
  2. Merck scraps £1bn expansion in the UK over lack of state investment  BBC
  3. MSD to Leave the London’s Francis Crick Institute’ Skylab as part of UK R&D Wind Down  PharmiWeb.com
  4. Pharma says UK is ‘tumbling down’ rankings for investment  pharmaphorum
  5. Merck Abandons $1.3B R&D Center in London, Boots 125 Employees  BioSpace

Continue Reading